Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Dutch Breast Cancer Research Group (BOOG)"'
Autor:
Stefanie de Groot, Rieneke T. Lugtenberg, Danielle Cohen, Marij J. P. Welters, Ilina Ehsan, Maaike P. G. Vreeswijk, Vincent T. H. B. M. Smit, Hiltje de Graaf, Joan B. Heijns, Johanneke E. A. Portielje, Agnes J. van de Wouw, Alex L. T. Imholz, Lonneke W. Kessels, Suzan Vrijaldenhoven, Arnold Baars, Elma Meershoek-Klein Kranenbarg, Marjolijn Duijm-de Carpentier, Hein Putter, Jacobus J. M. van der Hoeven, Johan W. R. Nortier, Valter D. Longo, Hanno Pijl, Judith R. Kroep, Dutch Breast Cancer Research Group (BOOG)
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
Preclinical evidence suggests that a fasting mimicking diet (FMD) can make cancer cells more vulnerable to chemotherapy, while protecting normal cells. In this randomized phase II clinical trial of 131 patients with HER2 negative early stage breast c
Externí odkaz:
https://doaj.org/article/ece7e746301b495eb80ac3a814697099
Autor:
Tjan-Heijnen, Vivianne C G, van Hellemond, Irene E G, Peer, Petronella G M, Swinkels, Astrid C P, Smorenburg, Carolien H, van der Sangen, Maurice J C, Kroep, Judith R, De Graaf, Hiltje, Honkoop, Aafke H, Erdkamp, Frans L G, van den Berkmortel, Franchette W P J, de Boer, Maaike, de Roos, Wilfred K, Linn, Sabine C, Imholz, Alexander L T, Seynaeve, Caroline M, Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators
Background The effect of extended adjuvant aromatase inhibition in hormone receptor-positive breast cancer after sequential endocrine therapy of tamoxifen followed by an aromatase inhibitor for a 5-year treatment period still needs clarification. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10691::dc5ca47db17d93c76b4e65ace8f3ce2c
https://dspace.library.uu.nl/handle/1874/360760
https://dspace.library.uu.nl/handle/1874/360760
Autor:
Claessens, Anouk K. M., Bos, Monique E. M. M., Lopez-Yurda, Marta, Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Honkoop, Aafke H., de Graaf, Hiltje, van Druten, Edith, van Warmerdam, Laurence J. C., van der Sangen, Maurice J. C., Tjan-Heijnen, Vivianne C. G., Erdkamp, Frans L. G., The Dutch Breast Cancer Research Group (BOOG)
Publikováno v:
Breast Cancer Research & Treatment; Nov2018, Vol. 172 Issue 2, p413-423, 11p
Autor:
van Hellemond, Irene E G, Vriens, Ingeborg J H, Peer, Petronella G M, Swinkels, Astrid C P, Smorenburg, Carolien H, Seynaeve, Caroline M, van der Sangen, Maurice J C, Kroep, Judith R, de Graaf, Hiltje, Honkoop, Aafke H, Erdkamp, Frans L G, van den Berkmortel, Franchette W P J, Kitzen, Jos J E M, de Boer, Maaike, de Roos, Wïlfred K, Linn, Sabine C, Imholz, Alexander L T, Tjan-Heijnen, Vivianne C G, Dutch Breast Cancer Research Group (BOOG)
Publikováno v:
JNCI: Journal of the National Cancer Institute; Dec2017, Vol. 109 Issue 12, pN.PAG-N.PAG, 1p
Autor:
van Ramshorst, Mette S1, van der Voort, Anna1, van Werkhoven, Erik D2, Mandjes, Ingrid A2, Kemper, Inge1, Dezentjé, Vincent O1,3, Oving, Irma M4, Honkoop, Aafke H5, Tick, Lidwine W6, van de Wouw, Agnes J7, Mandigers, Caroline M8, van Warmerdam, Laurence J9, Wesseling, Jelle10, Vrancken Peeters, Marie-Jeanne T11, Linn, Sabine C1,12, Sonke, Gabe S1 g.sonke@nki.nl, Dutch Breast Cancer Research Group (BOOG) (CORPORATE AUTHOR)
Publikováno v:
Lancet Oncology. Dec2018, Vol. 19 Issue 12, p1630-1640. 11p.
Autor:
Azim HA Jr; Cairo Cure Oncology Center, Cairo, Egypt.; Breast Cancer Center, Hospital Zambrano Hellion, School of Medicine, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico., Niman SM; International Breast Cancer Study Group Statistical Center, Boston, MA.; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Demeestere I; Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium.; Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium., Ruggeri M; Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Saura C; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Shimizu C; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan., Saetersdal AB; Breast Cancer Unit, Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Dutch Breast Cancer Research Group (BOOG), Amsterdam, the Netherlands., Mailliez A; Breast Cancer Unit, Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Warner E; Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada.; Canadian Clinical Trials Group (CCTG), Toronto, ON, Canada., Borges VF; Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, CO., Amant F; Department of Oncology, KU Leuven and Leuven Cancer Institute, Leuven, Belgium.; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.; Antoni van Leeuwenhoek-Netherlands Gynecologic Oncology Cancer Institute, Amsterdam, the Netherlands., Gombos A; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium., Kataoka A; Breast Oncology Cancer, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Centre, Centre Léon Bérard, Lyon, France., Borstnar S; Division of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia., Takei J; St Luke's International Hospital, Breast Center, Tokyo, Japan., Lee JE; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Department of Clinical Research and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea., Walshe JM; Cancer Trials Ireland, Dublin, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Tallaght University Hospital, Dublin, Ireland., Ruíz-Borrego M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Virgen del Rocio Sevilla, Sevilla, Spain., Moore HCF; Breast Oncology Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Saunders C; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Bjelic-Radisic V; Breast Unit, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany.; Medical University Graz, Department Gynaecology, Graz, Austria.; Austrian Breast and Colorectal Study Group (ABCSG), Vienna, Austria., Susnjar S; Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Klar NJ; New York University Langone's Perlmutter Cancer Center, Breast Cancer Center, New York, NY., Spanic T; Europa Donna, Ljubljana, Slovenia., Ruddy K; Department of Oncology, Mayo Clinic, Rochester, MN., Piccart M; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium., Korde LA; Breast and Melanoma Therapeutics, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Goldhirsch A; International Breast Cancer Study Group, Division of ETOP IBCSG Partners Foundation, Bern, Switzerland.; IEO, European Institute of Oncology, IRCCS, Milan, Italy., Gelber RD; International Breast Cancer Study Group Statistical Center, Boston, MA.; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Frontier Science Foundation, Boston, MA.; Harvard TH Chan School of Public Health, Boston, MA., Pagani O; Geneva University Hospitals, Geneva, Switzerland.; Lugano University, Lugano, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Peccatori FA; Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 10; Vol. 42 (23), pp. 2822-2832. Date of Electronic Publication: 2024 May 29.
Autor:
Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Voort A; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Seijen M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Thijssen B; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vonk S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mittempergher L; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Bhaskaran R; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Wilrijk, Antwerp, Belgium., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Apr 18; Vol. 10 (1), pp. 29. Date of Electronic Publication: 2024 Apr 18.
Autor:
Klaassen-Dekker A; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands. a.klaassen@iknl.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.klaassen@iknl.nl., Drossaert CHC; Health & Technology Department, University of Twente, Enschede, The Netherlands., Van Maaren MC; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Utrecht, The Netherlands., Retel VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Korevaar JC; Faculty of Health, Nutrition & Sport, The Hague University of Applied Sciences, The Hague, The Netherlands.; Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands., Siesling S; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Nov 14; Vol. 23 (1), pp. 1112. Date of Electronic Publication: 2023 Nov 14.
Autor:
Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Voort A; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Ramshorst MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vonk S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., van Leeuwen AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Kleijn M; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Mittempergher L; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Kuilman MM; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Glas AM; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2023 Jun 19; Vol. 25 (1), pp. 71. Date of Electronic Publication: 2023 Jun 19.
Autor:
Claessens AKM; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Busschbach JJV; Department of Psychiatry, Section of Medical Psychology and Psychotherapy, Erasmus Medical Centre, Rotterdam, The Netherlands., Ramaekers BLT; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands., Erdkamp FLG; Department of Medical Oncology, Zuyderland Medical Centre, Geleen, The Netherlands., Bouma JM; Department of Trial Registration, Comprehensive Cancer Centre the Netherlands, Rotterdam, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 May; Vol. 61 (5), pp. 619-624. Date of Electronic Publication: 2022 Feb 09.